This is a five-year (years-20 through -24) core grant renewal application for a comprehensive cancer center program embracing 317 member and associate member investigators who are UCLA faculty. The Jonson Comprehensive Cancer Center is a university-based matrix center and is comprised of three research divisions: Basic Research (three program areas). Clinical Research (four program areas), and transnational research, which often involves collaborations between members of different program areas or divisions. Core grant support is being requested for thirteen shared resources (core services) for Center investigators. Developmental funds are also being requested for new investigators and for a major new developmental shared resource. At the NCI's direction, administrative components from the previous core grant have been consolidated here in a single Administration budget. Since the last renewal application in 1988, seventeen new faculty investigators have been recruited to UCLA as members of the Cancer Center, and the total extramural support base (annual total costs) for Cancer Center members has increased form $60.1M in 1988 to $106.3M now (74.1M of which is peer reviewed research and $23.5M of which represents NCI support). Because of the existence of a Comprehensive Cancer Center at UCLA, the total product greatly """"""""exceeds the sum of the parts"""""""" which consist of individual research programs. Substantial new resources have also been drawn into a Cancer Center from institutional, community, and other research sponsors, as a direct result of NCI core support and the recognition of UCLA as an NCI-designed Comprehensive Cancer Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016042-20
Application #
2086401
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1977-12-01
Project End
1997-11-30
Budget Start
1994-04-01
Budget End
1994-11-30
Support Year
20
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Organized Research Units
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Black, David S; Cole, Steve W; Christodoulou, Georgia et al. (2018) Genomic mechanisms of fatigue in survivors of colorectal cancer. Cancer 124:2637-2644
Walser, Tonya C; Jing, Zhe; Tran, Linh M et al. (2018) Silencing the Snail-Dependent RNA Splice Regulator ESRP1 Drives Malignant Transformation of Human Pulmonary Epithelial Cells. Cancer Res 78:1986-1999
Chua, Bernadette Anne; Ngo, Jamie Ann; Situ, Kathy et al. (2018) Protein S and Gas6 induce efferocytosis of HIV-1-infected cells. Virology 515:176-190
Stanton, Annette L; Wiley, Joshua F; Krull, Jennifer L et al. (2018) Cancer-related coping processes as predictors of depressive symptoms, trajectories, and episodes. J Consult Clin Psychol 86:820-830
Glenn, Beth A; Hamilton, Ann S; Nonzee, Narissa J et al. (2018) Obesity, physical activity, and dietary behaviors in an ethnically-diverse sample of cancer survivors with early onset disease. J Psychosoc Oncol 36:418-436
Tsai, Wen-Ting K; Wu, Anna M (2018) Aligning physics and physiology: Engineering antibodies for radionuclide delivery. J Labelled Comp Radiopharm 61:693-714
Lisova, Ksenia; Sergeev, Maxim; Evans-Axelsson, Susan et al. (2018) Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors. Nucl Med Biol 61:36-44
Chang, Yu-Ling; Rossetti, Maura; Vlamakis, Hera et al. (2018) A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells. Mucosal Immunol :
Jia, Qingmei; Bowen, Richard; Dillon, Barbara Jane et al. (2018) Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia. Sci Rep 8:7009
Kiertscher, Sylvia M; Gangalum, Pallavi R; Ibrahim, Grace et al. (2018) A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers. J Neuroimmune Pharmacol 13:219-229

Showing the most recent 10 out of 767 publications